Signature research programmes
The complementary activities and expertise of the SCC founding institutions allow the integration of basic and clinical research with the development of effective translational research. It is via this synergy that the SCC can accelerate the transfer of innovation towards patient-care and thus offer cancer patients treatments which are both innovative and personalized.
Recent activities within the SCC have focused on building four signature programs:
- Immune Therapy
- Molecular Oncology & Targeted Therapeutics
- Precision Radiotherapy
- Nuclear Medicine and Molecular Imaging